Nearly 30% of patients experienced adenoma recurrence after polypectomy, and their risk patterns shifted over time based on polyp biology and patient characteristics. While high-grade dysplasia drove ...

In the article that accompanies this editorial, Pusztai et al 9 describe the development and validation of a new decision aide called RSClinN+ for women with estrogen receptor–positive, human ...

Combining USP8 genotype with tumor size identifies Cushing disease patients at high recurrence risk, even with low postoperative cortisol.

A risk score based on four factors — male sex, tumor size, World Health Organization (WHO) grade, and lymphovascular invasion — predicts recurrence in patients with node-negative pancreatic ...

Worries have persisted that cancer survivors in remission might face increased recurrence risk when treated with biologic drugs for autoimmune disease. This Danish study of rheumatoid arthritis ...

The chances of breast cancer recurring remain very low when patients are treated with radiotherapy that is tailored to their ...

PTNB before surgery in stage 1 NSCLC patients is linked to higher local-regional recurrence and mortality rates. The study included 2026 patients, with 38.6% undergoing PTNB, showing higher recurrence ...

Please provide your email address to receive an email when new articles are posted on . A mouthwash-based biomarker test has demonstrated efficacy for detecting risk of head and neck cancer recurrence ...

The likelihood of EGFR-positive lung cancer returning is largely tied to how advanced it is when first diagnosed, with lower chances in early stages and higher odds in later stages. Newer targeted ...

Please provide your email address to receive an email when new articles are posted on . Use of vaginal estrogen therapy does not affect recurrence risk for women previously diagnosed with endometrial ...

Despite secondary prevention with oral anticoagulation (OAC), the risk for recurrent ischemic stroke (IS) and mortality is high in patients with atrial fibrillation (AF). However, OAC discontinuation ...